What Are the Side Effects of GLP-1 Medications?
- John Linares, NP

- May 10
- 6 min read
Medically Reviewed by John Linares, NP
Every medication carries a benefit-risk calculation, and GLP-1 medications are no different. For patients considering semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro), understanding the full side effect profile is not just important — it's essential to making an informed decision and staying safe during treatment. Too often, people start these medications with an incomplete picture, which leads to either unnecessary alarm when side effects appear or dangerous complacency when something truly requires medical attention.
In this guide, I'm going to walk you through everything you need to know about GLP-1 side effects — the common ones that most patients experience and how to manage them, the less common but serious ones that require prompt medical attention, who should not take these medications, and how to work with your provider to ensure the safest possible experience.
The Most Common Side Effects: Gastrointestinal
By far the most frequently reported side effects of GLP-1 medications involve the gastrointestinal (GI) system. This makes biological sense: GLP-1 receptors are found throughout the digestive tract, and activating them pharmacologically affects how the gut functions. In clinical trials of semaglutide, GI side effects were reported in 70 to 80% of participants. Most were mild to moderate and improved significantly over time.
Nausea is the most common side effect, affecting up to 44% of patients in semaglutide trials. It tends to be worst in the first few weeks after starting a new dose and typically improves as the body adjusts. For most patients, it doesn't reach a level that causes them to stop treatment. Vomiting occurs less frequently but can be significant for some patients, particularly at higher doses. Diarrhea and constipation are both reported — they can alternate, which reflects the drug's complex effects on GI motility. Bloating, gas, burping, and feelings of stomach fullness are also common, especially in early treatment.
Acid reflux and heartburn are reported more frequently on GLP-1 medications than in placebo groups. Because these drugs slow gastric emptying, stomach contents remain in the stomach longer, which can increase acid exposure in the esophagus. Patients who already have GERD (gastroesophageal reflux disease) may find it worsens during treatment, and should discuss this with their provider before starting.
How to Minimize GI Side Effects
GI side effects are the primary reason patients discontinue GLP-1 medications prematurely. Understanding how to minimize them can be the difference between a successful treatment course and an avoidable dropout.
Start low and titrate slowly. GLP-1 medications use a dose escalation schedule for a reason: the body needs time to adapt. Rushing through dose increases or skipping the titration schedule dramatically increases side effect severity. If you're experiencing significant nausea at a given dose, it's completely reasonable to discuss staying at that dose for an extra month before escalating. Your timeline to the target dose is not a race.
Eat smaller, more frequent meals. Large meals place a significant demand on a stomach that is already emptying more slowly than usual. Eating smaller portions more frequently reduces nausea and bloating substantially for most patients. Avoid eating to the point of fullness — stop when you're satisfied, which will be earlier than you're used to.
Avoid high-fat, greasy, spicy, and strongly aromatic foods, especially in early treatment. These foods naturally slow gastric emptying on their own — combined with the drug's effect, they can cause significant nausea and discomfort. Plain, easy-to-digest foods are your best friends in the early weeks.
Stay hydrated. Vomiting and diarrhea can cause dehydration, which worsens nausea. Sip water, broth, or electrolyte beverages consistently throughout the day, even if you don't feel thirsty. Eat slowly and chew thoroughly. Rushing meals or swallowing air while eating contributes to bloating and GI discomfort.
Timing of the injection can also matter. Some patients find taking their weekly injection on a day when they can rest if needed (such as a Friday evening) helps them manage any post-dose nausea. Over-the-counter remedies like ginger, B6 supplements, and antacids may also help with mild nausea — ask your provider what they recommend.
Serious but Less Common Side Effects
While rare, there are more serious side effects associated with GLP-1 medications that require immediate medical attention. Knowing these warning signs is essential for patient safety.
Pancreatitis: Inflammation of the pancreas has been reported in patients taking GLP-1 medications. The risk appears to be low, but it is real. Warning signs include severe, persistent abdominal pain that may radiate to the back, often accompanied by nausea and vomiting. If you experience this, stop the medication and seek emergency medical care immediately. Do not resume GLP-1 therapy without clearance from a physician.
Thyroid tumors: In rodent studies, GLP-1 medications caused thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). While a direct causal link in humans has not been established, GLP-1 medications carry a boxed warning (the FDA's most serious warning) and are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). Patients should report any neck swelling, hoarseness, difficulty swallowing, or shortness of breath to their provider promptly.
Gallbladder disease: Rapid weight loss of any kind increases the risk of gallstones, and GLP-1 medications are no exception. Cholecystitis (gallbladder inflammation) and cholelithiasis (gallstones) are reported at higher rates in patients on GLP-1 therapy than in placebo groups. Symptoms include sharp pain in the upper right abdomen, especially after eating fatty meals, nausea, and fever. This is another situation requiring prompt medical evaluation.
Kidney injury: Severe dehydration from prolonged nausea and vomiting can contribute to acute kidney injury. This underscores the importance of staying well hydrated and seeking medical attention if vomiting becomes severe or persistent.
Vision changes: Some patients with diabetes taking semaglutide have reported diabetic retinopathy complications, particularly at the initiation of treatment. Rapid improvement in blood sugar control can paradoxically worsen retinopathy in the short term. Patients with existing eye disease should have their vision monitored when starting these medications.
Mental Health Side Effects: What We Know
Reports of depression, anxiety, suicidal ideation, and other mood changes in patients taking GLP-1 medications have prompted regulatory scrutiny. The FDA and EMA (European Medicines Agency) have reviewed the available data on this potential risk. To date, a definitive causal relationship has not been established — patients with obesity and type 2 diabetes already have elevated rates of depression, which makes it difficult to separate medication effects from background risk.
Interestingly, some research suggests that GLP-1 medications may actually improve mood and reduce symptoms of depression in some patients, possibly due to the neurological effects of GLP-1 receptors in the brain, improved metabolic health, and the psychological benefits of weight loss. The data is mixed, and the story is still evolving.
The practical guidance: if you notice significant changes in mood, increased anxiety, or any thoughts of self-harm after starting a GLP-1 medication, contact your provider immediately. Don't dismiss mood changes as unrelated — they deserve evaluation.
Who Should Not Take GLP-1 Medications?
GLP-1 medications are contraindicated in several groups. Pregnant individuals or those planning to become pregnant should not take these medications — they should be discontinued at least two months before attempting pregnancy. Patients with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome should not use GLP-1 medications due to the thyroid tumor risk. Those with a history of severe gastrointestinal conditions such as gastroparesis (delayed gastric emptying) should generally avoid GLP-1 therapy, as it may worsen their condition. Anyone with a known hypersensitivity or allergic reaction to the medication or its components should not take it.
Drug Interactions
Because GLP-1 medications slow gastric emptying, they can delay the absorption of oral medications taken at the same time. This is particularly important for medications where timing of absorption is critical — such as oral contraceptives, certain antibiotics, thyroid medications, and medications for seizures or heart conditions. Always provide your provider and pharmacist with a complete list of every medication and supplement you take before starting GLP-1 therapy. Adjustments to how and when you take other medications may be needed.
The Importance of Medical Supervision
I want to close with a message I give every patient who comes to me asking about GLP-1 medications: please do not obtain or use these medications without proper medical supervision. That means not purchasing them from unverified online sources, not using someone else's prescription, and not self-dosing without guidance.
The side effects I've described above are manageable — even the serious ones — when a qualified provider is monitoring you, knows your medical history, and can intervene early if something goes wrong. Without that oversight, patients may not recognize warning signs, may take inappropriate doses, and may miss interactions with other medications or conditions. Your safety is not worth compromising for convenience or cost savings.
GLP-1 medications represent a genuine medical advance for patients struggling with obesity and related conditions. Used appropriately, with proper screening, informed consent, and ongoing monitoring, they can be life-changing. Understanding their side effects — fully and honestly — is the foundation of using them safely.
— John Linares, NP | Prime Path Wellness


Comments